Dexcom Inc (DXCM)

$91.06 -1.28 (-1.39%)
Market Cap 34.85B
Revenue (ttm) 4.66B
Net Income (ttm) 836.30M
EPS (ttm) N/A
PE Ratio 35.38
Forward PE 34.11
Profit Margin 17.94%
Debt to Equity Ratio 0.47
Volume 4,451,336
Avg Vol 5,107,568
Day's Range N/A - N/A
Shares Out 377.36M
Stochastic %K 96%
Beta 1.41
Analysts Strong Sell
Price Target $93.07

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with predi...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
Stocktwits52wHighs
Stocktwits52wHighs Aug. 24 at 7:01 PM
$DXCM printed a new 52-week high today
0 · Reply
ShirleyThames338
ShirleyThames338 Aug. 24 at 9:41 AM
$KR $RJF $TWLO $NTRS $DXCM Kroger benefits from grocery demand and margins, Raymond James benefits from wealth-management activity, Twilio benefits from cloud communications demand, Northern Trust benefits from asset servicing and wealth management, and DexCom benefits from continuous-glucose-monitor adoption. I'm watching grocery margins, market activity, customer growth, asset flows, and healthcare adoption.
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 2:28 AM
$DXCM Price: $92.34 (+2.35%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.25% RSI: 62.7 | Momentum: Strong Momentum Volume: -39.7% vs avg Volatility: 3.24% Support: $72.00 | Resistance: $92.56 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 1:44 PM
$DXCM bs choose a direction
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 1:07 PM
$DXCM 83 is next support might retest 82-83 before ?
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 12:47 PM
$DXCM sell off incoming careful
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 4:43 AM
$DXCM fk it down 6-7%
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 10:07 PM
$DXCM triple top play might see 3-6% down tomorrow let see sell off Friday
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 8:56 PM
$DXCM breaking out to lower soon
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 8:54 PM
$DXCM there is a gap around 86 level hope we atleast get there soon
0 · Reply
Latest News on DXCM
The Big 3: PH, DXCM, UNP

Aug 20, 2026, 1:00 PM EDT - 4 days ago

The Big 3: PH, DXCM, UNP

DXCM PH UNP

Dexcom raises annual revenue forecast on strong demand for glucose monitors

Jul 30, 2026, 4:32 PM EDT - 25 days ago

Dexcom raises annual revenue forecast on strong demand for glucose monitors

DXCM

DexCom Earnings Call Transcript: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 25 days ago

DexCom Earnings Call Transcript: Q2 2026

DexCom Slides: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 25 days ago

DexCom Slides: Q2 2026

DexCom Earnings release: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 25 days ago

DexCom Earnings release: Q2 2026

DexCom Quarterly report: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 25 days ago

DexCom Quarterly report: Q2 2026

Dexcom Reports Second Quarter 2026 Financial Results

Jul 30, 2026, 4:02 PM EDT - 25 days ago

Dexcom Reports Second Quarter 2026 Financial Results

DXCM

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Jul 29, 2026, 9:12 AM EDT - 26 days ago

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

DXCM

Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program

Jul 22, 2026, 5:15 PM EDT - 4 weeks ago

Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program

DXCM

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Jul 13, 2026, 4:45 PM EDT - 6 weeks ago

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

DXCM

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

Jul 9, 2026, 8:30 AM EDT - 6 weeks ago

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

DXCM

Dexcom Further Advances Vision of Glucose Biosensing for All

Jun 23, 2026, 9:00 AM EDT - 2 months ago

Dexcom Further Advances Vision of Glucose Biosensing for All

DXCM

Living Longer Is Big Business. These Stocks Will Benefit.

Jun 18, 2026, 2:14 PM EDT - 2 months ago

Living Longer Is Big Business. These Stocks Will Benefit.

ABT DXCM GH HIMS PLNT

The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX

FDA clears first over-the-counter glucose monitor for children

Jun 12, 2026, 4:15 PM EDT - 2 months ago

FDA clears first over-the-counter glucose monitor for children

DXCM

Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction

Jun 11, 2026, 6:08 AM EDT - 2 months ago

Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction

DXCM

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

Jun 6, 2026, 2:49 PM EDT - 2 months ago

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

DXCM

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

Jun 6, 2026, 2:45 PM EDT - 2 months ago

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

DXCM

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

Jun 4, 2026, 9:00 AM EDT - 2 months ago

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

DXCM

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

Jun 2, 2026, 9:30 AM EDT - 2 months ago

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

DXCM

Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking

May 27, 2026, 9:07 AM EDT - 3 months ago

Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking

DXCM

Dexcom warns patients as stolen glucose sensors hit the market

May 26, 2026, 10:47 AM EDT - 3 months ago

Dexcom warns patients as stolen glucose sensors hit the market

DXCM

Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users

May 26, 2026, 9:30 AM EDT - 3 months ago

Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users

DXCM

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

May 18, 2026, 7:31 AM EDT - 3 months ago

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

DXCM

Dexcom to appoint two directors, revamp board committee with Elliott

May 14, 2026, 5:41 PM EDT - 3 months ago

Dexcom to appoint two directors, revamp board committee with Elliott

DXCM

DexCom Transcript: Investor Day 2026

May 14, 2026, 4:15 PM EDT - 3 months ago

DexCom Transcript: Investor Day 2026

DexCom Slides: FY 2026

May 14, 2026, 4:15 PM EDT - 3 months ago

DexCom Slides: FY 2026

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

May 14, 2026, 4:02 PM EDT - 3 months ago

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

DXCM

Dexcom to Host Investor Day on May 14, 2026

May 5, 2026, 8:30 AM EDT - 3 months ago

Dexcom to Host Investor Day on May 14, 2026

DXCM

Dexcom reaffirms full-year forecast after topping quarterly estimates

Apr 30, 2026, 4:52 PM EDT - 4 months ago

Dexcom reaffirms full-year forecast after topping quarterly estimates

DXCM

DexCom Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

DexCom Earnings Call Transcript: Q1 2026

DexCom Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

DexCom Earnings release: Q1 2026

DexCom Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

DexCom Slides: Q1 2026

DexCom Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

DexCom Quarterly report: Q1 2026

Dexcom Reports First Quarter 2026 Financial Results

Apr 30, 2026, 4:02 PM EDT - 4 months ago

Dexcom Reports First Quarter 2026 Financial Results

DXCM

DexCom Slides: Investor presentation

Apr 30, 2026, 7:00 AM EDT - 4 months ago

DexCom Slides: Investor presentation

DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 4 months ago

DexCom Proxy statement: Proxy filing

DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 4 months ago

DexCom Proxy statement: Proxy filing

Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time

Apr 2, 2026, 8:30 AM EDT - 5 months ago

Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time

DXCM

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

Mar 11, 2026, 2:00 AM EDT - 5 months ago

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

DXCM

DexCom Transcript: 47th Annual Raymond James Institutional Investor Conference

Mar 2, 2026, 1:05 PM EST - 6 months ago

DexCom Transcript: 47th Annual Raymond James Institutional Investor Conference

Dexcom Appoints Rick Osterloh to Board of Directors

Feb 26, 2026, 4:15 PM EST - 6 months ago

Dexcom Appoints Rick Osterloh to Board of Directors

DXCM

HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Feb 25, 2026, 8:00 PM EST - 6 months ago

HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

DXCM

Dexcom Announces Upcoming Conference Presentation

Feb 25, 2026, 8:30 AM EST - 6 months ago

Dexcom Announces Upcoming Conference Presentation

DXCM

The Big 3: VZ, DXCM, AMAT

Feb 19, 2026, 1:00 PM EST - 6 months ago

The Big 3: VZ, DXCM, AMAT

DXCM AMAT VZ

Dexcom beats quarterly estimates on strong demand for glucose monitors

Feb 12, 2026, 4:43 PM EST - 6 months ago

Dexcom beats quarterly estimates on strong demand for glucose monitors

DXCM

DexCom Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

DexCom Earnings Call Transcript: Q4 2025

DexCom Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

DexCom Annual report: Q4 2025

DexCom Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

DexCom Earnings release: Q4 2025

DexCom Slides: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

DexCom Slides: Q4 2025

Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Feb 12, 2026, 4:03 PM EST - 6 months ago

Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results

DXCM

DexCom Slides: Investor presentation

Feb 12, 2026, 7:00 AM EST - 6 months ago

DexCom Slides: Investor presentation

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

Feb 4, 2026, 8:30 AM EST - 7 months ago

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

DXCM

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

Jan 27, 2026, 8:30 AM EST - 7 months ago

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

DXCM

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Jan 15, 2026, 12:06 PM EST - 7 months ago

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

DXCM

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

Jan 13, 2026, 5:24 PM EST - 7 months ago

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

DXCM

DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 8 months ago

DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference

DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 8 months ago

DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Jan 12, 2026, 7:30 AM EST - 8 months ago

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

DXCM

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

Jan 7, 2026, 9:00 AM EST - 8 months ago

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

DXCM

Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

Dec 4, 2025, 8:02 AM EST - 9 months ago

Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

DXCM

Stocktwits52wHighs
Stocktwits52wHighs Aug. 24 at 7:01 PM
$DXCM printed a new 52-week high today
0 · Reply
ShirleyThames338
ShirleyThames338 Aug. 24 at 9:41 AM
$KR $RJF $TWLO $NTRS $DXCM Kroger benefits from grocery demand and margins, Raymond James benefits from wealth-management activity, Twilio benefits from cloud communications demand, Northern Trust benefits from asset servicing and wealth management, and DexCom benefits from continuous-glucose-monitor adoption. I'm watching grocery margins, market activity, customer growth, asset flows, and healthcare adoption.
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 2:28 AM
$DXCM Price: $92.34 (+2.35%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.25% RSI: 62.7 | Momentum: Strong Momentum Volume: -39.7% vs avg Volatility: 3.24% Support: $72.00 | Resistance: $92.56 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 1:44 PM
$DXCM bs choose a direction
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 1:07 PM
$DXCM 83 is next support might retest 82-83 before ?
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 12:47 PM
$DXCM sell off incoming careful
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 4:43 AM
$DXCM fk it down 6-7%
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 10:07 PM
$DXCM triple top play might see 3-6% down tomorrow let see sell off Friday
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 8:56 PM
$DXCM breaking out to lower soon
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 8:54 PM
$DXCM there is a gap around 86 level hope we atleast get there soon
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 8:27 PM
$DXCM expecting nice drop tomorrow
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 5:54 PM
$DXCM what happened to the lawsuits?
0 · Reply
MichaelMcmurray839
MichaelMcmurray839 Aug. 20 at 7:38 AM
$KR $RJF $TWLO $NTRS $DXCM Kroger benefits from grocery demand and margins, Raymond James benefits from wealth-management activity, Twilio benefits from cloud communications demand, Northern Trust benefits from asset servicing and wealth management, and DexCom benefits from continuous-glucose-monitor adoption. I'm watching grocery margins, market activity, customer growth, asset flows, and healthcare adoption.
0 · Reply
Typoon
Typoon Aug. 19 at 5:45 PM
$DXCM I was holding this for over a year. Close to 18 months and sold all my shares for a profit. Good luck to everyone else.
1 · Reply
JFDI
JFDI Aug. 18 at 2:21 PM
$DXCM sexy AF
0 · Reply
Chrissytina
Chrissytina Aug. 14 at 6:40 PM
$DXCM Today Must just be profit taking because I have seen no bad news, I’ve only seen upgrades and buy or strong buy signals 🤷🏼‍♀️ and Louis target price I’ve seen recently is $90 and as high as $105 is this just money for the w/end?
1 · Reply
howardlindzon
howardlindzon Aug. 14 at 6:32 PM
$DXCM been a long time since this printed 52 week highs. america just loves being fat and needing diabetes meds
1 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 14 at 6:31 PM
$DXCM printed a new 52-week high today
0 · Reply
JInvestTrade
JInvestTrade Aug. 14 at 1:25 AM
$ABT $DXCM $PODD $SENS $TNDM
1 · Reply
JInvestTrade
JInvestTrade Aug. 14 at 1:13 AM
$SENS $DXCM $ABT $TNDM $PODD https://lnkd.in/p/gUqQAkEB
0 · Reply
LupusLeoqueGlobalPartnrs
LupusLeoqueGlobalPartnrs Aug. 13 at 3:49 PM
Wait a minute... $DXCM $SENS We're coming for that sweet, sweet market share.
0 · Reply
Invest2live
Invest2live Aug. 12 at 6:22 PM
$DXCM 27% already; congrats 🔆🌷🔆 Checkout $CNC and $BSX; both have similar or better potential
0 · Reply